Azitra Inc (AZTR)

$0.23 -0.01 (-4.62%)
Market Cap 2.63M
Revenue (ttm) 10,000.00
Net Income (ttm) -8.97M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -89,700.00%
Debt to Equity Ratio 0.00
Volume 593,500
Avg Vol 837,994
Day's Range N/A - N/A
Shares Out 10.74M
Stochastic %K 16%
Beta -1.59
Analysts Strong Sell
Price Target $2.70

Company Profile

Azitra, Inc., an early-stage clinical biopharmaceutical company, develops therapies for precision dermatology using engineered proteins and live biotherapeutic products to treat skin diseases. It develops ATR-12, a genetically modified strain of S. epidermidis, which is in Phase Ib clinical trial for treating Netherton syndrome, a skin disease. The company also develops ATR-04, a genetically modified strain of S. epidermidis that is in Phase 1/2 clinical trial for treating the papulopustular ras...

Industry: Biotechnology
Sector: Healthcare
Phone: 203 646 6446
Address:
21 Business Park Drive, Branford, United States
JSP_Dilution_Player
JSP_Dilution_Player Feb. 3 at 8:39 PM
added few more today. catalysts/cash plays $TOVX $FATE $TCRX $VTGN $AZTR
0 · Reply
Evilmarine
Evilmarine Feb. 2 at 6:52 PM
$AZTR Green 🤩
2 · Reply
pbacher
pbacher Feb. 2 at 3:41 PM
$AZTR Oh, red... what a surprise -.-
0 · Reply
Aawilliam2003
Aawilliam2003 Jan. 31 at 5:39 PM
$AZTR these guys has $1.4 milllion left in cash at the end of Sept. sine then raised another $1.5. Their quarterly expenses are $2.8. How are they not bankrupt?
0 · Reply
pbacher
pbacher Jan. 30 at 9:13 PM
$AZTR S8 published. And again others know more they the public. This market is ridiculous
0 · Reply
pbacher
pbacher Jan. 30 at 3:16 PM
$AZTR Just when you think itcan't get any worse, this stock proves you wrong.
0 · Reply
OrbitalGecko
OrbitalGecko Jan. 28 at 8:49 PM
$AZTR
0 · Reply
JSP_Dilution_Player
JSP_Dilution_Player Jan. 28 at 4:34 PM
$AZTR go back over .30 and drop good data and move to .60.
0 · Reply
alfred_shll
alfred_shll Jan. 28 at 5:58 AM
$AZTR its time for $AZTR now poised
0 · Reply
alfred_shll
alfred_shll Jan. 28 at 1:10 AM
$AZTR yes baby. Lets go
0 · Reply
Latest News on AZTR
Azitra, Inc. to Present at Biotech Showcase Alongside the J.P. Morgan Annual Healthcare Conference

Jan 7, 2026, 8:00 AM EST - 27 days ago

Azitra, Inc. to Present at Biotech Showcase Alongside the J.P. Morgan Annual Healthcare Conference

Azitra Receives Notice of Acceptance of the Listing Standards Compliance Plan from NYSE American

Dec 17, 2025, 4:10 PM EST - 6 weeks ago

Azitra Receives Notice of Acceptance of the Listing Standards Compliance Plan from NYSE American

Azitra, Inc. Announces Pricing of $1.5 Million Private Placement Priced At a Premium To Market Under NYSE Rules

Nov 24, 2025, 9:00 AM EST - 2 months ago

Azitra, Inc. Announces Pricing of $1.5 Million Private Placement Priced At a Premium To Market Under NYSE Rules

Azitra, Inc. Announces Q3 2025 Results and Provides Business Updates

Nov 12, 2025, 5:15 PM EST - 2 months ago

Azitra, Inc. Announces Q3 2025 Results and Provides Business Updates

Azitra, Inc. Addresses False Report Regarding Sale of Securities

Nov 7, 2025, 6:00 AM EST - 3 months ago

Azitra, Inc. Addresses False Report Regarding Sale of Securities

Azitra, Inc. Announces Positive Preclinical Data for ATR-01 Program, Designed to Treat Ichthyosis Vulgaris

Oct 20, 2025, 8:02 AM EDT - 3 months ago

Azitra, Inc. Announces Positive Preclinical Data for ATR-01 Program, Designed to Treat Ichthyosis Vulgaris

Azitra Receives Notice of Non-Compliance from NYSE American

Oct 3, 2025, 4:45 PM EDT - 4 months ago

Azitra Receives Notice of Non-Compliance from NYSE American

Azitra, Inc. to Present at the H.C. Wainwright 27th Annual Global Investment Conference

Sep 4, 2025, 8:10 AM EDT - 5 months ago

Azitra, Inc. to Present at the H.C. Wainwright 27th Annual Global Investment Conference

Azitra, Inc. Announces First Patient Dosed in Phase 1/2 Trial for ATR-04 Program Targeting Oncology Patients with EGFRi-Associated Rash

Aug 27, 2025, 8:10 AM EDT - 5 months ago

Azitra, Inc. Announces First Patient Dosed in Phase 1/2 Trial for ATR-04 Program Targeting Oncology Patients with EGFRi-Associated Rash

Stock Market Today: Nasdaq, Dow, S&P 500 Futures Rise Ahead Of Powell's Speech At Jackson Hole—EpicQuest, Zoom, Azitra Stocks In Focus

Aug 22, 2025, 6:01 AM EDT - 5 months ago

Stock Market Today: Nasdaq, Dow, S&P 500 Futures Rise Ahead Of Powell's Speech At Jackson Hole—EpicQuest, Zoom, Azitra Stocks In Focus

IVV SPXL SPY SSO UPRO VOO ZM

Azitra, Inc. Announces Q2 2025 Results and Provides Business Updates

Aug 11, 2025, 5:00 PM EDT - 6 months ago

Azitra, Inc. Announces Q2 2025 Results and Provides Business Updates

Azitra, Inc. Announces Reverse Stock Split

Aug 11, 2025, 4:15 PM EDT - 6 months ago

Azitra, Inc. Announces Reverse Stock Split

Azitra Reports Promising Safety Data from Phase 1b Trial in Netherton Syndrome

Jun 17, 2025, 8:02 AM EDT - 8 months ago

Azitra Reports Promising Safety Data from Phase 1b Trial in Netherton Syndrome

Azitra, Inc. Announces Presentation at the 2025 BIO International Convention

Jun 10, 2025, 8:33 AM EDT - 8 months ago

Azitra, Inc. Announces Presentation at the 2025 BIO International Convention

Azitra, Inc. Announces Presentation at ASCO 2025 Highlighting Clinical Trial Investigating ATR-04 for EGFRi-Associated Rash

May 28, 2025, 8:33 AM EDT - 8 months ago

Azitra, Inc. Announces Presentation at ASCO 2025 Highlighting Clinical Trial Investigating ATR-04 for EGFRi-Associated Rash

Azitra, Inc. to Present Abstract at American Society of Gene and Cell Therapy Highlighting Phase 1/2 Study Targeting Cancer Therapy-Associated Rash

May 14, 2025, 4:05 PM EDT - 9 months ago

Azitra, Inc. to Present Abstract at American Society of Gene and Cell Therapy Highlighting Phase 1/2 Study Targeting Cancer Therapy-Associated Rash

Azitra, Inc. Announces Q1 2025 Results and Provides Business Updates

May 13, 2025, 5:06 PM EDT - 9 months ago

Azitra, Inc. Announces Q1 2025 Results and Provides Business Updates

Azitra, Inc. to Present ATR-04 Program Update at ASCO 2025

Apr 25, 2025, 8:33 AM EDT - 10 months ago

Azitra, Inc. to Present ATR-04 Program Update at ASCO 2025

Azitra Announces Share Purchase Agreement for up to $20 Million in Partnership with Alumni Capital to Fund Clinical Pipeline

Apr 24, 2025, 4:05 PM EDT - 10 months ago

Azitra Announces Share Purchase Agreement for up to $20 Million in Partnership with Alumni Capital to Fund Clinical Pipeline

Azitra to Present at Microbiome Times Partnering Forum

Mar 12, 2025, 8:33 AM EDT - 11 months ago

Azitra to Present at Microbiome Times Partnering Forum

Azitra, Inc. Announces Full Year 2024 Financial Results and Provides Business Updates

Feb 24, 2025, 8:30 AM EST - 1 year ago

Azitra, Inc. Announces Full Year 2024 Financial Results and Provides Business Updates

Azitra Announces Pricing of $930.0 Thousand Registered Direct Offering of Common Stock

Feb 4, 2025, 2:20 PM EST - 1 year ago

Azitra Announces Pricing of $930.0 Thousand Registered Direct Offering of Common Stock

Azitra, Inc. to Present at the BIO CEO & Investor Conference

Feb 3, 2025, 9:05 AM EST - 1 year ago

Azitra, Inc. to Present at the BIO CEO & Investor Conference

Azitra, Inc. to Present at The Microcap Conference

Jan 27, 2025, 4:05 PM EST - 1 year ago

Azitra, Inc. to Present at The Microcap Conference

Azitra Announces Pricing of $1.5 Million Public Offering of Common Stock

Jan 15, 2025, 8:30 AM EST - 1 year ago

Azitra Announces Pricing of $1.5 Million Public Offering of Common Stock

Azitra Announces Proposed Public Offering of Common Stock

Jan 14, 2025, 4:05 PM EST - 1 year ago

Azitra Announces Proposed Public Offering of Common Stock

Azitra, Inc. Announces Q3 2024 Financial Results and Provides Business Updates

Nov 12, 2024, 5:05 PM EST - 1 year ago

Azitra, Inc. Announces Q3 2024 Financial Results and Provides Business Updates

Azitra to Present at BIO-Europe 2024

Oct 29, 2024, 9:00 AM EDT - 1 year ago

Azitra to Present at BIO-Europe 2024

Azitra to Participate in the 2024 Maxim Healthcare Virtual Summit

Oct 11, 2024, 9:00 AM EDT - 1 year ago

Azitra to Participate in the 2024 Maxim Healthcare Virtual Summit

Azitra, Inc. Announces Late-Breaking Presentation at the European Academy of Dermatology and Venereology Congress

Sep 24, 2024, 8:00 AM EDT - 1 year ago

Azitra, Inc. Announces Late-Breaking Presentation at the European Academy of Dermatology and Venereology Congress

Azitra Receives Fast Track Designation for ATR-04 for Skin Rash from EGFR Inhibitors

Sep 18, 2024, 9:00 AM EDT - 1 year ago

Azitra Receives Fast Track Designation for ATR-04 for Skin Rash from EGFR Inhibitors

Azitra to Present at the H.C. Wainwright 26th Annual Global Investment Conference

Sep 6, 2024, 4:30 PM EDT - 1 year ago

Azitra to Present at the H.C. Wainwright 26th Annual Global Investment Conference

Azitra Announces First Patient Dosed in Phase 1b Trial of ATR-12 for Netherton Syndrome

Aug 28, 2024, 8:30 AM EDT - 1 year ago

Azitra Announces First Patient Dosed in Phase 1b Trial of ATR-12 for Netherton Syndrome

Azitra Receives Study May Proceed letter from the FDA for IND to Treat Skin Rash from EGFR Inhibitors

Aug 22, 2024, 9:00 AM EDT - 1 year ago

Azitra Receives Study May Proceed letter from the FDA for IND to Treat Skin Rash from EGFR Inhibitors

Azitra Announces First Patient Screened and Scheduled to Enroll in Phase 1b Trial of ATR-12 for Netherton Syndrome

Aug 20, 2024, 4:15 PM EDT - 1 year ago

Azitra Announces First Patient Screened and Scheduled to Enroll in Phase 1b Trial of ATR-12 for Netherton Syndrome

Azitra, Inc. Announces Q2 2024 Financial Results and Provides Business Updates

Aug 12, 2024, 6:23 PM EDT - 1 year ago

Azitra, Inc. Announces Q2 2024 Financial Results and Provides Business Updates

CORRECTING and REPLACING Azitra, Inc. Announces Closing of $10.0 Million Public Offering

Jul 25, 2024, 5:57 PM EDT - 1 year ago

CORRECTING and REPLACING Azitra, Inc. Announces Closing of $10.0 Million Public Offering

You.com Announces Strategic Collaboration With Moesif to Drive Productivity and Power Usage-Based Billing

Jul 25, 2024, 1:54 PM EDT - 1 year ago

You.com Announces Strategic Collaboration With Moesif to Drive Productivity and Power Usage-Based Billing

HAL

Wingspire Equipment Finance's $12 Million Funding Initiative to Propel Tier 1 Aerospace Manufacturer Capabilities

Jul 25, 2024, 1:13 PM EDT - 1 year ago

Wingspire Equipment Finance's $12 Million Funding Initiative to Propel Tier 1 Aerospace Manufacturer Capabilities

HAL

Azitra, Inc. Announces Pricing of $10.0 Million Public Offering

Jul 23, 2024, 9:20 PM EDT - 1 year ago

Azitra, Inc. Announces Pricing of $10.0 Million Public Offering

Azitra, Inc. Strengthens Global Intellectual Property Portfolio with Newly Granted and Allowed Patents

Jul 23, 2024, 8:00 AM EDT - 1 year ago

Azitra, Inc. Strengthens Global Intellectual Property Portfolio with Newly Granted and Allowed Patents

Azitra, Inc. Announces Presentation at the 2024 BIO International Convention

May 31, 2024, 8:00 AM EDT - 1 year ago

Azitra, Inc. Announces Presentation at the 2024 BIO International Convention

Azitra, Inc. Announces Positive Preclinical Data from ATR-04 Presented at the Society of Investigative Dermatology Annual Meeting

May 17, 2024, 8:00 AM EDT - 1 year ago

Azitra, Inc. Announces Positive Preclinical Data from ATR-04 Presented at the Society of Investigative Dermatology Annual Meeting

Azitra, Inc. Announces Positive Preclinical Data of ATR-12 and Clinical Design in Netherton Syndrome Presented at the ASGCT Annual Meeting

May 10, 2024, 8:00 AM EDT - 1 year ago

Azitra, Inc. Announces Positive Preclinical Data of ATR-12 and Clinical Design in Netherton Syndrome Presented at the ASGCT Annual Meeting

Azitra, Inc. Announces Q1 2024 Financial Results and Provides Business Updates

May 9, 2024, 5:00 PM EDT - 1 year ago

Azitra, Inc. Announces Q1 2024 Financial Results and Provides Business Updates

Azitra, Inc. Announces New Preclinical Data to be Presented at the American Society of Gene and Cell Therapy Meeting

Apr 22, 2024, 4:30 PM EDT - 1 year ago

Azitra, Inc. Announces New Preclinical Data to be Presented at the American Society of Gene and Cell Therapy Meeting

Azitra, Inc. to Present New Data at Three Upcoming Scientific Conferences in May 2024

Apr 18, 2024, 4:15 PM EDT - 1 year ago

Azitra, Inc. to Present New Data at Three Upcoming Scientific Conferences in May 2024

Azitra, Inc. Announces Full Year 2023 Financial Results and Provides Business Updates

Mar 15, 2024, 4:15 PM EDT - 2 years ago

Azitra, Inc. Announces Full Year 2023 Financial Results and Provides Business Updates

Azitra, Inc. Announces Closing of Public Offering

Feb 16, 2024, 4:05 PM EST - 2 years ago

Azitra, Inc. Announces Closing of Public Offering

Azitra, Inc. Announces Pricing of Public Offering

Feb 13, 2024, 10:09 PM EST - 2 years ago

Azitra, Inc. Announces Pricing of Public Offering

JSP_Dilution_Player
JSP_Dilution_Player Feb. 3 at 8:39 PM
added few more today. catalysts/cash plays $TOVX $FATE $TCRX $VTGN $AZTR
0 · Reply
Evilmarine
Evilmarine Feb. 2 at 6:52 PM
$AZTR Green 🤩
2 · Reply
pbacher
pbacher Feb. 2 at 3:41 PM
$AZTR Oh, red... what a surprise -.-
0 · Reply
Aawilliam2003
Aawilliam2003 Jan. 31 at 5:39 PM
$AZTR these guys has $1.4 milllion left in cash at the end of Sept. sine then raised another $1.5. Their quarterly expenses are $2.8. How are they not bankrupt?
0 · Reply
pbacher
pbacher Jan. 30 at 9:13 PM
$AZTR S8 published. And again others know more they the public. This market is ridiculous
0 · Reply
pbacher
pbacher Jan. 30 at 3:16 PM
$AZTR Just when you think itcan't get any worse, this stock proves you wrong.
0 · Reply
OrbitalGecko
OrbitalGecko Jan. 28 at 8:49 PM
$AZTR
0 · Reply
JSP_Dilution_Player
JSP_Dilution_Player Jan. 28 at 4:34 PM
$AZTR go back over .30 and drop good data and move to .60.
0 · Reply
alfred_shll
alfred_shll Jan. 28 at 5:58 AM
$AZTR its time for $AZTR now poised
0 · Reply
alfred_shll
alfred_shll Jan. 28 at 1:10 AM
$AZTR yes baby. Lets go
0 · Reply
revuelto
revuelto Jan. 28 at 12:56 AM
$AZTR even in the best case where atr12 works, dilution will be story here for sometime…..✌️
0 · Reply
JSP_Dilution_Player
JSP_Dilution_Player Jan. 27 at 7:20 PM
$AZTR no r/s risk anytime soon as they just did in Aug last year. ATR-04 has $1 billion sales potential and current market is very tiny for this bio.
0 · Reply
JSP_Dilution_Player
JSP_Dilution_Player Jan. 27 at 5:04 PM
$AZTR keep eye on this one this month and in Feb. This should start moving up as we get closer to data. Low market cap and $200 million market potential and then there is another drug that has $1 billion market potential
0 · Reply
Victity
Victity Jan. 26 at 9:34 PM
$AZTR garbage!
0 · Reply
ProFloat
ProFloat Jan. 26 at 8:47 PM
$AZTR
0 · Reply
SevenPhigs27
SevenPhigs27 Jan. 26 at 6:48 PM
$AZTR Threw in a starter. GL to all.
1 · Reply
ChartChartist
ChartChartist Jan. 25 at 7:58 PM
$RENX pennies will be a thing again after nano floats $AEHL nano float $AZTR .26 lows
0 · Reply
dln101
dln101 Jan. 22 at 7:55 PM
$ADIL or $AZTR will bounce like $AMZE first? 🤔💪🔥🚀
0 · Reply
pbacher
pbacher Jan. 22 at 4:29 PM
$AZTR let´s be honest. If we don´t get an update asap, a big update, we´re heading straight into a new atl.
0 · Reply
actiontime77
actiontime77 Jan. 22 at 12:55 PM
$AZTR surprised at lack of interest here. Company should update
0 · Reply
pbacher
pbacher Jan. 21 at 4:49 PM
$AZTR of course... haha, just laughable
0 · Reply
pbacher
pbacher Jan. 21 at 9:40 AM
$AZTR hello beauty =D Next try, give us news
0 · Reply